Price movement over the last 24 hours
Alcon AG vs Atmos Energy Corporation — how do they compare? Alcon AG trades at $66.79 (market cap $32.69B), while Atmos Energy Corporation trades at $177.69 (market cap $29.64B). The key difference: Alcon AG and Atmos Energy Corporation are close in size by market cap, and Atmos Energy Corporation pays the higher dividend (2.25%). Which is the better fit depends on your goals.
| ALC | ATO | |
|---|---|---|
Market Cap | $32.69B | $29.64B |
Sector | Health | Utilities |
52-Week High | $92.22 | $192.25 |
52-Week Low | $62.02 | $151.99 |
Enterprise Value | $36.28B | $39.15B |
Dividend Yield | 0.54% | 2.25% |
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
ATO trades at $177.58, up 0.4% today, with a bearish technical signal but neutral oscillators. Recent earnings beat expectations in Q1 2026, with revenue growth to $4.7B in 2025 and a net margin of 27.58%. The stock shows strong profitability and a P/E of 21.41, while analyst consensus is a Buy with a $188.86 target. A dividend of $1.00 was recently declared, supporting income appeal.
Outlook is positive due to earnings beats and defensive utility positioning, but risks include high capital expenditures and debt levels. Investment opportunity lies in steady growth and dividend consistency, though market volatility and interest rate sensitivity pose challenges for near-term performance.
Trailing returns across standard periods
Latest headlines on both assets
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Atmos Energy is the largest publicly traded, fully regulated, pure-play natural gas utility in the United States, serving more than 3 million customers in Texas, Colorado, Kansas, Kentucky, Louisiana, Mississippi, Tennessee, and Virginia. About two thirds of its earnings come from Texas, where it distributes natural gas in northern Texas and owns an intrastate gas pipeline spanning several key shale gas formations and interconnected with five storage facilities.
Read more on ATO →